How Drug Interactions Work

The Two Root Causes of Drug Interactions

Every drug interaction, whether between two prescriptions, a drug and a supplement, or a medication and a food, traces back to one of two fundamental mechanisms. Either the body processes the drug differently when another substance is present (pharmacokinetic), or the two substances compete for or amplify the same biological effect (pharmacodynamic).

The distinction matters because it determines the clinical outcome. A pharmacokinetic interaction typically raises or lowers blood levels of the affected drug. A pharmacodynamic interaction can be dangerous even when blood levels are normal.

Pharmacokinetic Interactions: ADME

Pharmacokinetics describes what the body does to a drug, captured in the acronym ADME: Absorption, Distribution, Metabolism, and Excretion. An interaction at any of these stages can alter how much drug reaches its target.

Absorption Interactions

Some drugs change the environment in the GI tract, affecting how much of another drug enters the bloodstream. Common examples:

• Antacids and thyroid drugs - calcium carbonate can bind to levothyroxine in the gut and reduce absorption. Individual product labels contain any administration directions.
• Proton pump inhibitors and ketoconazole - PPIs reduce stomach acid, impairing absorption of drugs that need acidic pH to dissolve.
• Cholestyramine (bile acid sequestrant) - binds to many drugs in the GI tract (warfarin, digoxin, thyroid hormones), drastically reducing their absorption.

Metabolism Interactions: The CYP450 System

The liver's cytochrome P450 enzyme system is the site of most clinically significant drug interactions. These enzymes, especially CYP3A4, CYP2D6, CYP2C9, and CYP2C19, break down the majority of prescription medications.

When two drugs share the same CYP enzyme, they compete, and the one that loses gets metabolized more slowly, building up to higher concentrations. Alternatively, one drug may inhibit or induce the enzyme itself:

• Enzyme inhibitors block CYP enzymes, causing other drugs to accumulate. Example: Fluoxetine (Prozac) inhibits CYP2D6, raising blood levels of certain antidepressants, opioids, and antipsychotics that rely on CYP2D6 for clearance.
• Enzyme inducers increase CYP enzyme production, accelerating drug metabolism. Example: Rifampin (an antibiotic) is a powerful CYP3A4 inducer that can cut blood levels of hormonal contraceptives by 50–80%, leading to unintended pregnancy.

Excretion Interactions

Some drugs affect how kidneys eliminate other drugs. The transporter protein P-glycoprotein (P-gp) controls kidney and intestinal excretion of many drugs. Inhibiting P-gp raises levels; inducing it lowers them.

• Digoxin + amiodarone - amiodarone inhibits P-gp, raising digoxin levels by 50–100%, potentially causing digoxin toxicity (nausea, vision changes, arrhythmia).
• NSAIDs + lithium - NSAIDs reduce kidney clearance of lithium, raising levels. Since lithium has a narrow therapeutic index, even a modest increase can cause toxicity.

Pharmacodynamic Interactions: Same Target, Different Drugs

Pharmacodynamic interactions occur when two drugs act on the same receptor, enzyme, or physiological pathway. Blood levels of each drug may be perfectly normal, but the combined effect is stronger or weaker than expected.

Additive Interactions

Two drugs with the same effect simply add up. Two mild sedatives together equal one strong sedative. This is predictable and usually dose-dependent.

Synergistic Interactions

The combined effect is greater than additive, the classic "1 + 1 = 3" scenario. Alcohol plus a benzodiazepine is a dangerous synergistic CNS depressant combination. Both separately depress the central nervous system, but together they can cause respiratory depression and death at doses that individually would be safe.

Antagonistic Interactions

One drug partially or fully blocks the effect of another at the receptor level. Beta-blockers (used for heart conditions) block beta-2 receptors in the lungs, opposing the action of bronchodilators used for asthma. The result: the asthma medication becomes less effective.

Interaction Types by Severity

Not all interactions are equally dangerous. The FDA and clinical databases classify interactions by severity. Understanding this spectrum helps prioritize which interactions require immediate action versus monitoring.

The CYP450 Enzyme Map

Knowing which enzyme a drug uses, and whether other drugs inhibit or induce that enzyme - is the core of predicting pharmacokinetic interactions. The table below shows the major CYP enzymes, key substrates (drugs metabolized by that enzyme), common inhibitors, and common inducers.

High-Risk Drug Combinations from FDA Data

The FDA's Adverse Event Reporting System (FAERS) consistently highlights certain drug combinations as disproportionately associated with serious outcomes. These are not the only dangerous interactions, but they represent patterns that appear repeatedly in clinical reports.

• Warfarin + anything - warfarin is the most interaction-prone drug in clinical use. It is metabolized by CYP2C9, bound tightly to albumin, and has a narrow therapeutic index. Over 200 drugs and dozens of foods and supplements alter its effect.
• MAOIs + serotonergic drugs - monoamine oxidase inhibitors prevent serotonin breakdown. Adding SSRIs, SNRIs, or even triptans can cause serotonin syndrome: agitation, confusion, high fever, rapid heart rate, and in severe cases, death.
• ACE inhibitors + potassium-sparing diuretics - both raise potassium levels. Combined, they can cause dangerous hyperkalemia (high blood potassium), leading to cardiac arrhythmias.
• Fluoroquinolone antibiotics + antacids - divalent cations in antacids (magnesium, aluminum, calcium) chelate fluoroquinolones in the gut, reducing absorption by 50–90% and making the antibiotic ineffective.
• Opioids + benzodiazepines - both depress the central nervous system, and together they sharply raise the risk of slowed breathing, overdose, and death. The combination is serious enough that the FDA requires a Boxed Warning on both drug classes about co-prescribing.

Food-Drug Interactions: Beyond Grapefruit

Food-drug interactions are underestimated and underreported. While grapefruit is the most famous, several other foods alter drug pharmacokinetics:

• Leafy green vegetables (vitamin K) - FDA labeling identifies vitamin K intake as relevant to warfarin management. The amount and clinical meaning depend on the individual record.
• High-fat meals + certain drugs - food can change absorption for some products. The applicable instructions are the ones attached to that product's FDA label.
• Dairy products + antibiotics - calcium in dairy can bind tetracyclines and some fluoroquinolones, reducing absorption. PlainMeds does not translate that label fact into a personal timing instruction.
• Alcohol + acetaminophen - chronic heavy alcohol use induces CYP2E1, which converts acetaminophen to a toxic metabolite (NAPQI). Heavy drinkers face increased risk of acetaminophen-induced liver damage even at recommended doses.

Check Your Interactions

The FDA publishes interaction data in official drug labels for every prescription medication. PlainMeds aggregates this data in its interaction database and links each record to the relevant FDA-label drug profile.